ApoCa of the breast, particularly PAC, does not appear to be enriched with the stromal TIL, which, along with low-PD-L1, low TMB, and microsatellite stable status known from previous studies, make these cancers less amenable to the treatment with ICI. This evidence concerns the gene CD274 and cancer.